BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md Imtaiyaz Hassan. Investigating the role of transcription factors of pancreas development in pancreatic cancerPancreatology 2018; 18(2): 184 doi: 10.1016/j.pan.2017.12.013
2
Eri Yoshida, Daisuke Kudo, Hayato Nagase, Hiroshi Shimoda, Shinichiro Suto, Mika Negishi, Ikuko Kakizaki, Masahiko Endo, Kenichi Hakamada. Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancerOncology Letters 2016; 12(4): 2337 doi: 10.3892/ol.2016.4930
3
David Witte, Franziska Zeeh, Thomas Gädeken, Frank Gieseler, Bernhard Rauch, Utz Settmacher, Roland Kaufmann, Hendrik Lehnert, Hendrik Ungefroren. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic CancerJournal of Clinical Medicine 2016; 5(12): 111 doi: 10.3390/jcm5120111
4
Noemi Garcia-Romero, Susana Esteban-Rubio, Gorjana Rackov, Josefa Carrión-Navarro, Cristobal Belda-Iniesta, Angel Ayuso-Sacido. Extracellular vesicles compartment in liquid biopsies: Clinical applicationMolecular Aspects of Medicine 2018; 60: 27 doi: 10.1016/j.mam.2017.11.009
5
Sheng Chen, Ye Wang, Wen-Long Zhang, Mao-Sheng Dong, Jian-Hua Zhang. Sclareolide enhances gemcitabine-induced cell death through mediating the NICD and Gli1 pathways in gemcitabine-resistant human pancreatic cancerMolecular Medicine Reports 2017; 15(4): 1461 doi: 10.3892/mmr.2017.6182
6
Hang Yin, ShaoPeng Wang, Yu-Hang Zhang, Yu-Dong Cai, Hailin Liu. Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic CancerBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/7861274
7
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitroInternational Journal of Molecular Medicine 2015; 35(6): 1773 doi: 10.3892/ijmm.2015.2164
8
MASAYOSHI YAMAGUCHI, SATORU OSUKA, M. NEALE WEITZMANN, BASSEL F. EL-RAYES, MAMORU SHOJI, TOMIYASU MURATA. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitroInternational Journal of Oncology 2016; 48(5): 1955 doi: 10.3892/ijo.2016.3409
9
Masayoshi Yamaguchi, Tomiyasu Murata. Potential suppressive effects of gentian violet on human breast cancer MDA-MB-231 cells in vitro: Comparison with gemcitabineOncology Letters 2016; 12(2): 1605 doi: 10.3892/ol.2016.4773
10
Cui-Juan Qian, Yi-Yi Chen, Xin Zhang, Fu-Qiang Liu, Ting-Ting Yue, Bei Ye, Jun Yao. Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cellsOncology Letters 2016; 12(5): 3499 doi: 10.3892/ol.2016.5097
11
Md. Faiz Ahmad, Sarah E. Huff, John Pink, Intekhab Alam, Andrew Zhang, Kay Perry, Michael E. Harris, Tessianna Misko, Suheel K. Porwal, Nancy L. Oleinick, Masaru Miyagi, Rajesh Viswanathan, Chris Godfrey Dealwis. Identification of Non-nucleoside Human Ribonucleotide Reductase ModulatorsJournal of Medicinal Chemistry 2015; 58(24): 9498 doi: 10.1021/acs.jmedchem.5b00929
12
J.C. Hunter, N.S. Gray, K.D. Westover. Conquering RAS2017; : 155 doi: 10.1016/B978-0-12-803505-4.00009-6
13
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesWorld Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
14
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA, BASSEL F. EL-RAYES, MAMORU SHOJI. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabineOncology Reports 2015; 34(6): 3304 doi: 10.3892/or.2015.4282
15
Masayoshi Yamaguchi. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastasesMolecular and Cellular Biochemistry 2016; 421(1-2): 193 doi: 10.1007/s11010-016-2803-1
16
Dejun Yang, Jian Shi, Hongbing Fu, Ziran Wei, Jiapeng Xu, Zunqi Hu, Yu Zhang, Ronglin Yan, Qingping Cai. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomasTumor Biology 2016; 37(9): 12315 doi: 10.1007/s13277-016-5061-7
17
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari, Ali Zandi-Karimi. Nanotechnology for delivery of gemcitabine to treat pancreatic cancerBiomedicine & Pharmacotherapy 2017; 88: 635 doi: 10.1016/j.biopha.2017.01.071
18
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA. Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitroMolecular Medicine Reports 2015; 12(5): 7801 doi: 10.3892/mmr.2015.4352
19
Masayoshi Yamaguchi, Satoru Osuka, M. Neale Weitzmann, Mamoru Shoji, Tomiyasu Murata. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitroInternational Journal of Oncology 2016; 49(2): 812 doi: 10.3892/ijo.2016.3538
20
Hendrik Ungefroren, David Witte, Bernhard Rauch, Utz Settmacher, Hendrik Lehnert, Frank Gieseler, Roland Kaufmann. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β SignalingInternational Journal of Molecular Sciences 2017; 18(11): 2494 doi: 10.3390/ijms18112494
21
Kimberly M. Arnold, Lynn M. Opdenaker, Daniel Flynn, Jennifer Sims-Mourtada. Wound Healing and Cancer Stem Cells: Inflammation as a Driver of Treatment Resistance in Breast CancerCancer Growth and Metastasis 2015; 8: CGM.S11286 doi: 10.4137/CGM.S11286
22
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA, MAMORU SHOJI, M. NEALE WEITZMANN. The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastasesInternational Journal of Oncology 2015; 47(4): 1563 doi: 10.3892/ijo.2015.3106
23
Zongchang Song, Wenying Liu, Yu Xiao, Minghui Zhang, Yan Luo, Weiwei Yuan, Yu Xu, Guanzhen Yu, Yide Hu, Keping Xie. PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric CancerPLOS ONE 2015; 10(8): e0128943 doi: 10.1371/journal.pone.0128943
24
Wei Xiong, Wen-Hui Li, Yong-Xin Jiang, Shan Liu, Yi-Qin Ai, Rong Liu, Li Chang, Ming Zhang, Xiao-Li Wang, Han Bai, Hong Wang, Rui Zheng, Jing Tan. Parecoxib: an Enhancer of Radiation Therapy for Colorectal CancerAsian Pacific Journal of Cancer Prevention 2015; 16(2): 627 doi: 10.7314/APJCP.2015.16.2.627
25
Masayoshi Yamaguchi, Satoru Osuka, M. Neale Weitzmann, Bassel F. El-Rayes, Mamoru Shoji, Tomiyasu Murata. Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitroInternational Journal of Oncology 2016; 49(4): 1686 doi: 10.3892/ijo.2016.3669
26
Julia Baguña Torres, James C. Knight, Michael J. Mosley, Veerle Kersemans, Sofia Koustoulidou, Danny Allen, Paul Kinchesh, Sean Smart, Bart Cornelissen. Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal AntibodyMolecular Imaging and Biology 2018; 20(2): 292 doi: 10.1007/s11307-017-1112-8
27
S Calabretta, P Bielli, I Passacantilli, E Pilozzi, V Fendrich, G Capurso, G Delle Fave, C Sette. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cellsOncogene 2016; 35(16): 2031 doi: 10.1038/onc.2015.270
28
Masayoshi Yamaguchi, Satoru Osuka, Mamoru Shoji, M. Neale Weitzmann, Tomiyasu Murata. Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitroMolecular and Cellular Biochemistry 2017; 430(1-2): 37 doi: 10.1007/s11010-017-2952-x
29
Jia-Qiang Zhang, Shi Chen, Jiang-Ning Gu, Yi Zhu, Qian Zhan, Dong-Feng Cheng, Hao Chen, Xia-Xing Deng, Bai-Yong Shen, Cheng-Hong Peng. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cellsJournal of Cellular Biochemistry 2018; 119(1): 1027 doi: 10.1002/jcb.26270